Sumitomo Financial Statements From 2010 to 2024
| DNPUFDelisted Stock | USD 4.37 0.00 0.00% |
Check Sumitomo Dainippon financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Sumitomo Dainippon's main balance sheet or income statement drivers, such as , as well as many indicators such as . Sumitomo financial statements analysis is a perfect complement when working with Sumitomo Dainippon Valuation or Volatility modules.
Sumitomo |
Sumitomo Dainippon Pharma Company Operating Margin Analysis
Sumitomo Dainippon's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Sumitomo Dainippon Operating Margin | (0.03) % |
Most of Sumitomo Dainippon's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sumitomo Dainippon Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
CompetitionBased on the recorded statements, Sumitomo Dainippon Pharma has an Operating Margin of -0.0273%. This is 99.92% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 99.5% lower than that of the firm.
Sumitomo Dainippon Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sumitomo Dainippon's current stock value. Our valuation model uses many indicators to compare Sumitomo Dainippon value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sumitomo Dainippon competition to find correlations between indicators driving Sumitomo Dainippon's intrinsic value. More Info.Sumitomo Dainippon Pharma is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Sumitomo Dainippon's earnings, one of the primary drivers of an investment's value.About Sumitomo Dainippon Financial Statements
Sumitomo Dainippon stakeholders use historical fundamental indicators, such as Sumitomo Dainippon's revenue or net income, to determine how well the company is positioned to perform in the future. Although Sumitomo Dainippon investors may analyze each financial statement separately, they are all interrelated. For example, changes in Sumitomo Dainippon's assets and liabilities are reflected in the revenues and expenses on Sumitomo Dainippon's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Sumitomo Dainippon Pharma. Please read more on our technical analysis and fundamental analysis pages.
Sumitomo Pharma Co., Ltd. engages in the manufacture and sale of pharmaceuticals, food ingredients and additives, veterinary medicines, and others in Japan, North America, China, and internationally. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Dai Nippon operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 6987 people.
Currently Active Assets on Macroaxis
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Consideration for investing in Sumitomo Pink Sheet
If you are still planning to invest in Sumitomo Dainippon Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sumitomo Dainippon's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |